The MidAtlantic Fund is a venture fund and family office that meets the need for seed and early stage funding for mobile technology, healthcare and service companies, as well as investing in new and growing venture funds. As vanguard investors, we seek start-up opportunities needing investments that range from $100,000 up to a few million. We’re here to support companies that are led by great teams who produce innovative technologies with clear revenue models. It’s our financial support, coupled with our early stage experience and active involvement that provides an investment and operating edge for the companies we work with.
Through our hands-on approach, we create financial value for companies and transform them into highly successful businesses.
It’s the complementary mix of our powerful industry experience, advisory support and capital contribution that provides value to our companies.
Advanced orthodontic medical device that is patented FDA registered, for use with any orthodontic treatment modality.
Development of Continuing Medical Education (CME) programs for the pharmaceutical and healthcare industries. Sold to Interpublic Group (NYSE: IPG).
Innovative platforms for large number of target physicians to be impacted by brands key messages and value to pharmaceutical clients. Sold to Interpublic Group (NYSE: IPG).
Leader in digital internet broadcasting for healthcare companies, reaching millions of users with live, real-time, fully interactive programming. Sold to Interpublic Group (NYSE: IPG).
Strategic promotional initiatives for pharmaceutical brand teams to ensure alignment of brand strategy, product life cycle and market environment. Sold to Interpublic Group (NYSE: IPG).
Privacy IT company protecting shared data including text messages, emails, pictures and publically placed information.
State-of-the-art outpatient facility that offers a full spectrum of services in the areas of physical therapy, rehabilitation and sports care.
A medical device company that treats debilitating spinal conditions, such as Lumbar Spinal Stenosis (LSS) through minimally invasive alternatives to surgical procedures.
An integrated Marketing Communications company providing traditional, digital and multimedia marketing for the pharmaceutical and bio-technology industries. Sold to Quintiles Transnational.
Network of licensed, primary care physicians providing members around-the-clock, 24x7, phone access to medical consults from anywhere at any time. IPO 2015 (NASDAQ: TDOC).
A specialty respiratory pharmaceutical company acquired by Meda in 2013.
A high-tech consumer product to stimulate growth activity within facial bones to reverse the appearance of aging as bones shrink over time.